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Post-traumatic isolated superior rectus hematoma
Sir, An eight-year-old boy presented with post-traumatic right-sided periorbital ecchymosis and swelling of the eyelid with palpebral fissure closure. A few days later he was unable to fully open the eye and was complained of diplopia. On examination, he had normal visual acuity and fields. The right eye was mildly proptosed and depressed, with periorbital ecchymosis and swelling [ Figure 1a ]. There was no subconjunctival or scleral hemorrhage. Fundoscopic examination was normal. Extraocular movements were normal in the left eye. He was able to move the right eye in all directions except superiorly. Forced duction test of the right eye was negative. A CT scan of the brain and orbits showed a hematoma in the superior rectus-levator complex [ Figure 1b -d]. No fracture was seen. The patient was treated conservatively and eye movements gradually improved.
Isolated hemorrhage into an ocular muscle following trauma is very uncommon. Only one case of isolated posttraumatic superior rectus hematoma has been reported in the English literature to date. [1] More frequent are reports of inferior rectus hematoma. The commonest cause of a post-traumatic diplopia is mechanical entrapment of soft tissues due to a blow out of the orbital floor. Hemorrhage and edema in the orbital fat causing septae to become taut, can also restrict ocular movement. In both of these conditions, forced duction test is positive. However, in injury to the ocular muscles, the forced duction test is negative. [2] Isolated hemorrhage into ocular muscles does not have any other characteristic clinical feature to distinguish them from other causes of posttraumatic diplopia. Evidence of a bleed may be seen, if the hematoma extends along the muscle sheath to its insertion on the globe. [3] The paucity of clinical findings to distinguish this rare phenomenon from the more 
Azithromycin-induced myasthenic crisis: Reversibility with calcium gluconate
Sir, Infections that precipitate acute exacerbations of myasthenia gravis (MG) are managed with antibiotics which themselves have the potential to worsen MG. We report the case of a boy with MG in whom intravenous (iv) azithromycin caused sudden worsening of motor symptoms necessitating endotracheal intubation. The respiratory weakness improved within a few minutes of inravenous (iv) calcium gluconate administration followed by improvement in limb power. Such a rapid reversal suggests that azithromycin probably acts presynaptically suppressing acetylcholine release. Since there is no harmful effect of iv calcium gluconate in postsynaptic defects, we advocate such treatment in all cases of acute worsening of MG due to antibiotics or other substances with less clear site of action.
Several antibiotics are known to worsen myasthenia gravis (MG). Still their administration becomes necessary in dire situations. Aminoglycosides are well known to worsen MG. [1] About some newer antibiotics, such adverse effects are not clearly known. However, there are some anecdotal reports of exacerbation of MG with macrolides, such as azithromycin and telithromycin. [2, 3] No definite remedy is known for such worsening. We report a case of acute worsening of MG with a macrolide antibiotic azithromycin, which dramatically improved with intravenous (iv) administration of calcium gluconate. As trials on human beings are not possible in specific situations, experience gained over a period of time makes our understanding better. It is for this reason that pharmacovigilance efforts should continue even long after marketing of drugs.
A 13-year-old boy presented to the emergency services with acute onset painless difficulty in swallowing with drooling of saliva for two days and generalized weakness for one day. He had had similar symptoms twice in the last one year; on both the occasions, he had responded to iv steroids administered empirically without getting a definite diagnosis. Examination revealed bilateral ptosis without other extraocular weakness, pharyngeal weakness with a nasal twang in voice, neck weakness, and proximal limb weakness. Fatigability could be demonstrated in all groups of muscles. There were no sensory signs and deep tendon reflexes were normal. The child had tonsillitis with bilateral tonsilar hypertrophy. Chest X-ray and CT revealed pneumonia involving left lower lobe without any mediastinal enlargement to suggest thymic hyperplasia.
With the provisional diagnosis of MG, a neostigmine test was performed to which the response was immediate and significant. In addition to low dose oral steroids (prednisolone (10 mg/day) and pyridostigmine (60 mg thrice a day)) that he received for two days, iv azithromycin (500 mg single dose infused in one hour) was administered in view of the evidence of active tonsilitis and pneumonia. Within 10min utes of receiving iv azithromycin, the child started having respiratory distress, became cyanosed and unresponsive. He was immediately intubated, put on mechanical ventilator, and administered iv calcium gluconate. Ten minutes later he regained consciousness and started flexing his neck and moving his limbs against gravity. He was put off the ventilator after two hours and could be easily extubated the next day. Over the next 10 days, the dose of prednisolone was gradually increased while pyridostigmine was continued. The ptosis and extraocular paresis improved almost completely, the nasal twang in speech decreased, and the swallowing improved. At the time of discharge, the boy was able to walk and perform his self-care activities.
Aminoglycoside antibiotics are well known to impair neuromuscular transmission, which can be partially reversed by cholinesterase inhibitors and aminopyridines. [1, 4, 5] Some animal studies have suggested reversal of neuromuscular transmission block by the infusion of iv calcium. [4] Other antibiotics including tetracyclines, sulfonamides, penicillins, amino acid antibiotics, and fluoroquinolones have either been associated with anecdotal reports of increased weakness in myasthenic patients or implicated from in vitro studies to adversely affect neuromuscular transmission. [6] [7] [8] 
